TOKYO -- Olympus will acquire South Korean stent maker Taewoong Medical for about $370 million in its second-biggest acquisition ever, the Japanese medical devices company said on Friday.
The deal marks a major expansion for the world's leading endoscope maker as it looks to beef up its medical device offerings and find new revenue sources outside its core strength in optical equipment.
